nicotine has been researched along with tacrolimus in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Fitzsimonds, RM; Krueger, SR; Picciotto, MR; Stevens, TR | 1 |
| Dehpour, AR; Ghasemi, M; Kalbasi Anaraki, D; Nezami, BG; Rahimpour, S; Sadeghi, M; Sianati, S | 1 |
| Choi, BS; Chung, BH; Cui, S; Ding, J; Jiang, YJ; Jin, JZ; Jin, YJ; Lee, JP; Li, C; Luo, K; Nan, QY; Piao, SG; Xuan, MY; Yang, CW; Zheng, HL | 1 |
8 other study(ies) available for nicotine and tacrolimus
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Bungarotoxins; Calcineurin; Calcineurin Inhibitors; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Cerebral Cortex; Glutamic Acid; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Neurotoxins; Nicotine; Nifedipine; Receptors, Nicotinic; Tacrolimus | 2003 |
Pharmacological preconditioning of random-pattern skin flaps with local FK506 in nicotine-treated rats: interaction with nitric oxide system.
Topics: Animals; Dose-Response Relationship, Drug; Graft Survival; Immunosuppressive Agents; Male; Nicotine; Nitric Oxide; Rats; Skin Transplantation; Surgical Flaps; Tacrolimus; Transplantation Conditioning | 2009 |
Nicotine exacerbates tacrolimus-induced renal injury by programmed cell death.
Topics: Animals; Apoptosis; Kidney; Nicotine; Rats; Rats, Sprague-Dawley; Tacrolimus | 2021 |